In-line filter occlusion during intravenous delivery of injectable menatetrenone (vitamin K2)

Toshiaki Sendo, K. Adachi, K. Otsubo, T. Aoyama, R. Oishi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Filter occlusion during intravenous infusion of injectable menatetrenone in an electrolyte fluid was examined. The menatetrenone concentration and its emulsion droplet size were not changed by in-line filtration. However, particle counts in the admixed solution and examination of scanning electron micrographs of the surface of the filter membrane indicated that particle formation occurred immediately after the admixture of menatetrenone injection with Hicaliq No. 2, but not with 5% glucose injection. This may be due to the interaction of excess lecithin in the emulsion with the electrolyte. Filter occlusion also occurred with the admixture of menatetrenone-free emulsion and Hicaliq No. 2, but not with 5% glucose injection. These findings indicate that injectable menatetrenone should not be admixed with electrolyte fluids.

Original languageEnglish
Pages (from-to)9-13
Number of pages5
JournalJournal of Clinical Pharmacy and Therapeutics
Volume21
Issue number1
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Vitamin K 2
Injections
Emulsions
Electrolytes
Glucose
Lecithins
Intravenous Infusions
menatetrenone
Electrons
Membranes

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

In-line filter occlusion during intravenous delivery of injectable menatetrenone (vitamin K2). / Sendo, Toshiaki; Adachi, K.; Otsubo, K.; Aoyama, T.; Oishi, R.

In: Journal of Clinical Pharmacy and Therapeutics, Vol. 21, No. 1, 1996, p. 9-13.

Research output: Contribution to journalArticle

@article{f05196f1c15f426abd9d544c365057a9,
title = "In-line filter occlusion during intravenous delivery of injectable menatetrenone (vitamin K2)",
abstract = "Filter occlusion during intravenous infusion of injectable menatetrenone in an electrolyte fluid was examined. The menatetrenone concentration and its emulsion droplet size were not changed by in-line filtration. However, particle counts in the admixed solution and examination of scanning electron micrographs of the surface of the filter membrane indicated that particle formation occurred immediately after the admixture of menatetrenone injection with Hicaliq No. 2, but not with 5{\%} glucose injection. This may be due to the interaction of excess lecithin in the emulsion with the electrolyte. Filter occlusion also occurred with the admixture of menatetrenone-free emulsion and Hicaliq No. 2, but not with 5{\%} glucose injection. These findings indicate that injectable menatetrenone should not be admixed with electrolyte fluids.",
author = "Toshiaki Sendo and K. Adachi and K. Otsubo and T. Aoyama and R. Oishi",
year = "1996",
language = "English",
volume = "21",
pages = "9--13",
journal = "Journal of Clinical Pharmacy and Therapeutics",
issn = "0269-4727",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - In-line filter occlusion during intravenous delivery of injectable menatetrenone (vitamin K2)

AU - Sendo, Toshiaki

AU - Adachi, K.

AU - Otsubo, K.

AU - Aoyama, T.

AU - Oishi, R.

PY - 1996

Y1 - 1996

N2 - Filter occlusion during intravenous infusion of injectable menatetrenone in an electrolyte fluid was examined. The menatetrenone concentration and its emulsion droplet size were not changed by in-line filtration. However, particle counts in the admixed solution and examination of scanning electron micrographs of the surface of the filter membrane indicated that particle formation occurred immediately after the admixture of menatetrenone injection with Hicaliq No. 2, but not with 5% glucose injection. This may be due to the interaction of excess lecithin in the emulsion with the electrolyte. Filter occlusion also occurred with the admixture of menatetrenone-free emulsion and Hicaliq No. 2, but not with 5% glucose injection. These findings indicate that injectable menatetrenone should not be admixed with electrolyte fluids.

AB - Filter occlusion during intravenous infusion of injectable menatetrenone in an electrolyte fluid was examined. The menatetrenone concentration and its emulsion droplet size were not changed by in-line filtration. However, particle counts in the admixed solution and examination of scanning electron micrographs of the surface of the filter membrane indicated that particle formation occurred immediately after the admixture of menatetrenone injection with Hicaliq No. 2, but not with 5% glucose injection. This may be due to the interaction of excess lecithin in the emulsion with the electrolyte. Filter occlusion also occurred with the admixture of menatetrenone-free emulsion and Hicaliq No. 2, but not with 5% glucose injection. These findings indicate that injectable menatetrenone should not be admixed with electrolyte fluids.

UR - http://www.scopus.com/inward/record.url?scp=0029917472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029917472&partnerID=8YFLogxK

M3 - Article

C2 - 8737177

AN - SCOPUS:0029917472

VL - 21

SP - 9

EP - 13

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

SN - 0269-4727

IS - 1

ER -